FAGIX
Price
$11.20
Change
-$0.05 (-0.44%)
Updated
Jul 24 closing price
Net Assets
16.02B
RITEX
Price
$9.75
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Net Assets
28.55B
Interact to see
Advertisement

FAGIX vs RITEX

FAGIX vs RITEX Comparison Chart in %
View a ticker or compare two or three
VS
FAGIX vs. RITEX commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAGIX is a Hold and RITEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RITEX has more cash in the bank: 28.6B vs. FAGIX (16B). RITEX pays higher dividends than FAGIX: RITEX (6.35) vs FAGIX (4.44). FAGIX was incepted earlier than RITEX: FAGIX (49 years) vs RITEX (24 years). FAGIX (0.88) is less costly to investors than RITEX (0.70). RITEX is a more actively managed with annual turnover of: 40.00 vs. FAGIX (26.00). FAGIX has a lower initial minimum investment than RITEX: FAGIX (0) vs RITEX (250). FAGIX annual gain was more profitable for investors over the last year : 11.04 vs. RITEX (5.34). FAGIX (26.08) and RITEX (24.93) have equivalent 5 years return.
FAGIXRITEXFAGIX / RITEX
Total Expense Ratio0.860.70123%
Annual Report Gross Expense Ratio0.880.70126%
Fund Existence49 years24 years-
Gain YTD5.2271.424367%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets16B28.6B56%
Annual Yield % from dividends4.446.3570%
Returns for 1 year11.045.34207%
Returns for 3 years38.0928.36134%
Returns for 5 years26.0824.93105%
Returns for 10 years84.6175.14113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OASVX15.020.15
+1.01%
Optimum Small-Mid Cap Value A
IOEZX21.130.20
+0.96%
ICON Equity Income Institutional
NWXVX12.060.03
+0.25%
Nationwide International Sm Cp Instl Svc
PGEJX28.690.01
+0.03%
George Putnam Balanced R6
BBGSX17.41-0.16
-0.91%
Bridge Builder Small/Mid Cap Growth